Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth

2 Dec 2022

Abstract excerpt

BACKGROUND: Dopamine receptors have been reported to play important roles in cancer progression. However, the role of dopamine receptor D3 (DRD3) in hepatocellular carcinoma (HCC) remains unclear. METHODS: The expression of DRD3 was detected by immunohistochemistry and real-time qPCR. The prognostic value of DRD3 in patients was investigated by analyzing selected databases, including cBioPortal and Kaplan-Meier...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Breast Cancer Therapies
Share to Cancer Cells and Metastasis
Share to Cancer, Stress, Anesthesia, and Immune Response

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36456906
DOI: 10.1186/s12885-022-10368-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growthPMID 36456906Read ↗

HTR1D regulates the PI3K/Akt signaling pathway to impact hepatocellular carcinoma development and resistance to sorafenibSemantic proximity Read ↗

DRD4 promotes chemo-resistance and cancer stem cell-like phenotypes by mediating the activation of the Akt/β-catenin signaling axis in liver cancer.Semantic proximity Read ↗

CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistanceSemantic proximity Read ↗

Dopamine-induced SULT1A3/4 promotes EMT and cancer stemness in hepatocellular carcinomaSemantic proximity Read ↗

Discoidin Domain Receptor 1 Promotes Hepatocellular Carcinoma Progression through Modulation of SLC1A5 ExpressionSemantic proximity Read ↗

PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancerSemantic proximity Read ↗

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinomaSemantic proximity Read ↗

Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathwaySemantic proximity Read ↗

XPD suppresses cell proliferation and migration via miR-29a-3p-Mdm2/PDGF-B axis in HCCSemantic proximity Read ↗

Overexpression of WAVE3 promotes tumor invasiveness and confers an unfavorable prognosis in human hepatocellular carcinomaSemantic proximity Read ↗

Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinomaSemantic proximity Read ↗

RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.